No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Advarra Announces Appointment of Jonathan E. Shough as President, Technology Solutions

Editor: What To Know

  • “His proven expertise in developing and commercializing innovative technology solutions to improve the drug development process will further cement our position as the leader in practice management systems for clinical research and the preferred site technology partner for sponsors and CROs.
  • Prior to that, he held the position of Senior Vice President and Chief Data Officer at Syneos Health where he was responsible for developing and executing the data and commercialization strategy.
  • “As we continue to evolve our technology offerings to empower sites and build connections across the clinical research ecosystem, Jonathan is a perfect fit to lead our efforts, and we’re pleased to welcome him to Advarra,”.

Advarra, the market leader in clinical research practice management technology, regulatory review solutions, and research quality and compliance consulting services, announced today that it has named Jonathan E. Shough to the position of President, Technology Solutions.

Shough brings over 30 years of experience in information technology, including more than 20 years in the clinical research industry. He will be a member of the executive leadership team, reporting directly to Gadi Saarony, Advarra CEO. Shough will be responsible for managing Advarra’s technology business segment, driving product strategy and offerings, commercialization, and customer relationships.

onathan E. Shough

“As we continue to evolve our technology offerings to empower sites and build connections across the clinical research ecosystem, Jonathan is a perfect fit to lead our efforts, and we’re pleased to welcome him to Advarra,” commented Saarony. “His proven expertise in developing and commercializing innovative technology solutions to improve the drug development process will further cement our position as the leader in practice management systems for clinical research and the preferred site technology partner for sponsors and CROs.”

Most recently, Shough was Senior Vice President and CIO, LabCorp Drug Development and GM Software Platforms, where he managed a large data and technology team and worked on several successful mergers and acquisitions. Prior to that, he held the position of Senior Vice President and Chief Data Officer at Syneos Health where he was responsible for developing and executing the data and commercialization strategy. At IQVIA, Shough served as executive director, IT, where he developed the technology go-to-market strategy and supported technology development. Earlier in his career, he held numerous information technology leadership positions in the financial and telecommunications industries. Shough attended Guilford College and is a US Marine Corps veteran.

“I am passionate about bringing the power of technology to improve the drug development process,” Shough said. “I’m excited to join Advarra and help progress their strategic vision to connect sites, CROs, and sponsors through technology.”

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy